Gas chromatography-mass spectrometry determination of nicotine and cotinine in urine: A study of the effect of passive smoking.
Journal
Rapid communications in mass spectrometry : RCM
ISSN: 1097-0231
Titre abrégé: Rapid Commun Mass Spectrom
Pays: England
ID NLM: 8802365
Informations de publication
Date de publication:
30 Sep 2024
30 Sep 2024
Historique:
revised:
12
06
2024
received:
16
04
2024
accepted:
14
06
2024
medline:
8
7
2024
pubmed:
8
7
2024
entrez:
7
7
2024
Statut:
ppublish
Résumé
Recent data suggest that passive smoking has a risk comparable to active smoking. Passive smoking is considered dangerous in children and is suspected as a cause of asthma. However, some reports are opposing such claims, indicating the need for solid results and large-scale studies. This scientific work aims to develop a method for the determination of nicotine (NCOT) and major nicotine's metabolite cotinine (COT) in urine samples, using gas chromatography-mass spectrometry (GC-MS). Analysis was performed using a gas chromatograph Agilent Technologies 7890A with an MS 5975C inert XL, EI/CI MSD with Triple-Axis detector. For sample preparation, liquid-liquid extraction was applied after an optimization study with different extraction media. Eventually, 1 mL of dichloromethane was selected for the extraction of 0.5 mL of urine. Suitable chromatographic conditions were found for the rapid and accurate determination of NCOT and COT. Injection of 2 μL was performed using GC-MS, and selected ion monitoring (SIM) analysis was performed with the following ions (m/z): 162 (quantifier ion) and 84, 133, 161 qualifier ions for NCOT, and 176 (quantifier ion) and 98, 118, 119, 147 qualifier ions for COT. Nicotine-D4 (NCOT-D4) and cotinine-D3 (COT-D3) were used as internal standards with quantifier ions 101 and 166, respectively. The retention time (Rt) for NCOT was 7.557 min and 9.743 min for COT. The method was validated following international principles, assessing characteristics such as absolute recovery, carryover, linearity, specificity, selectivity, accuracy, precision, and stability. The method showed a linear dynamic range from 0.5 to 50 ng/mL, and the limits of detection and quantification were for both NCOT and COT 0.2 and 0.5 ng/mL, respectively. Validation results were found satisfactory. Finally, the method was applied to the analysis of 60 clinical pediatric samples obtained from Aristotle University's pediatric clinic to check for possible exposure to smoke. Concentration levels ranged between 0.5 and 16.2 ng/mL for NCOT and between 1.0 and 25.1 ng/mL for COT. A rapid, sensitive, accurate, and simple method was developed and used as a tool for the confirmation of passive smoking in children. It is the first method applied to the analysis of such samples belonging to nonsmokers of young age. The total runtime of the GC-MS analysis was short (20 min), and the pretreatment protocol was simple, giving the ability for analysis of a large number of samples on a daily routine basis.
Substances chimiques
Cotinine
K5161X06LL
Tobacco Smoke Pollution
0
Nicotine
6M3C89ZY6R
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e9864Informations de copyright
© 2024 John Wiley & Sons Ltd.
Références
Benowitz NL, Hukkanen J, Jacob P. Nicotine chemistry, metabolism, kinetics and biomarkers. In: Henningfield JE, London ED, Pogun S, eds. Nicotine Psychopharmacology. Springer; 2009:29‐60. doi:10.1007/978‐3‐540‐69248‐5_2
Lee H‐S, Cho J‐H, Lee Y‐J, Park D‐S. Effect of second‐hand smoke exposure on establishing urinary cotinine‐based optimal cut‐off values for smoking status classification in Korean adults. Int J Environ Res Public Health. 2022;19(13):7971. doi:10.3390/ijerph19137971
Paci E, Pigini D, Bauleo L, Ancona C, Forastiere F, Tranfo G. Urinary cotinine concentration and self‐reported smoking status in 1075 subjects living in Central Italy. Int J Environ Res Public Health. 2018;15(4):804. doi:10.3390/ijerph15040804
Avila‐Tang E, al‐Delaimy WK, Ashley DL, et al. Assessing secondhand smoke using biological markers. Tob Control. 2013;22(3):164‐171. doi:10.1136/tobaccocontrol‐2011‐050298
Armstrong DW, Wang X, Ercal N. Enantiomeric composition of nicotine in smokeless tobacco, medicinal products, and commercial reagents. Chirality. 1998;10(7):587‐591. doi:10.1002/(SICI)1520‐636X(1998)10:7<587::AID‐CHIR6>3.0.CO;2‐#
Miller EI, Norris H‐RK, Rollins DE, Tiffany ST, Wilkins DG. A novel validated procedure for the determination of nicotine, eight nicotine metabolites and two minor tobacco alkaloids in human plasma or urine by solid‐phase extraction coupled with liquid chromatography–electrospray ionization–tandem mass spectrometry. J Chromatogr B. 2010;878(9‐10):725‐737. doi:10.1016/j.jchromb.2009.12.018
Gallart‐Mateu D, Elbal L, Armenta S, de la Guardia M. Passive exposure to nicotine from e‐cigarettes. Talanta. 2016;152:329‐334. doi:10.1016/j.talanta.2016.02.014
Scheidweiler KB, Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, cotinine, trans‐3′‐hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography–tandem mass spectrometry. Clin Chim Acta. 2012;413(11‐12):978‐984. doi:10.1016/j.cca.2012.02.017
De Cremer K, Van Overmeire I, Van Loco J. On‐line solid‐phase extraction with ultra performance liquid chromatography and tandem mass spectrometry for the detection of nicotine, cotinine and trans‐3′‐hydroxycotinine in urine to strengthen human biomonitoring and smoking cessation studies. J Pharm Biomed Anal. 2013;76:126‐133. doi:10.1016/j.jpba.2012.12.018
Man CN, Gam L‐H, Ismail S, Lajis R, Awang R. Simple, rapid and sensitive assay method for simultaneous quantification of urinary nicotine and cotinine using gas chromatography–mass spectrometry. J Chromatogr B. 2006;844(2):322‐327. doi:10.1016/j.jchromb.2006.07.029
Shin H‐S, Kim J‐G, Shin Y‐J, Jee SH. Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography–mass spectrometry. J Chromatogr B. 2002;769(1):177‐183. doi:10.1016/S1570‐0232(02)00007‐7
Kardani F, Daneshfar A, Sahrai R. Determination of nicotine, anabasine, and cotinine in urine and saliva samples using single‐drop microextraction. J Chromatogr B. 2010;878(28):2857‐2862. doi:10.1016/j.jchromb.2010.08.041
Massadeh AM, Gharaibeh AA, Omari KW. A single‐step extraction method for the determination of nicotine and cotinine in Jordanian Smokers' blood and urine samples by RP‐HPLC and GC‐MS. J Chromatogr Sci. 2009;47(2):170‐177. doi:10.1093/chromsci/47.2.170
Dural E, İşiner B, Boran E, Söylemezoğlu T. Validation of GC–MS method for determination of nicotine and cotinine in plasma and urine. Toxicol Lett. 2011;205:S199‐S200. doi:10.1016/j.toxlet.2011.05.687
ICH. Validation of analytical procedures: text and methodology Q2(R1). Available at: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. (Accessed: 19/03/2024)
Eurachem. The Fitness for Purpose of Analytical Methods. A Laboratory Guide to Method Validation and Related Topics. Available at: https://www.eurachem.org/images/stories/Guides/pdf/MV_guide_2nd_ed_EN.pdf. (Accessed: 19/03/2024)
FDA. Analytical Procedures and Methods Validation for Drugs and Biologics. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/analytical-procedures-and-methods-validation-drugs-and-biologics (Accessed: 19/03/2024).
Jung BH, Chung BC, Chung SJ, Lee MH, Shim CK. Simultaneous GC‐MS determination of nicotine and cotinine in plasma for the pharmacokinetic characterization of nicotine in rats. J Pharm Biomed Anal. 1999;20(1‐2):195‐202. doi:10.1016/S0731‐7085(99)00020‐5
Avgeri M, Haidopoulou K, Raikos N, et al. Do parental smoking habits differ in children with asthma/wheezing disorders? Health Sci J. 2017;11(5). doi:10.21767/1791‐809X.1000524
Matsumoto A, Ino T, Ohta M, et al. Enzyme‐linked immunosorbent assay of nicotine metabolites. Environ. Health Prev. Med. 2010;15(4):211‐216. doi:10.1007/s12199‐009‐0129‐2
Dempsey D, Jacob P III, Benowitz NL. Nicotine metabolism and elimination kinetics in newborns. Clin Pharmacol Ther. 2000;67(5):458‐465. doi:10.1067/mcp.2000.106129
Matsumoto A, Matsumoto A, Ichiba M, Payton NM, Oishi H, Hara M. Simultaneous measurement of urinary total nicotine and cotinine as biomarkers of active and passive smoking among Japanese individuals. Environ Health Prev Med. 2013;18(3):244‐250. doi:10.1007/s12199‐012‐0307‐5